-transparent.png){kind=logo}
The immune adherence hemagglutination assay was found to be as sensitive and specific as the indirect immunofluorescence technique for titration of antibodies to Epstein-Barr virus capsid antigen. Satisfactory virus capsid antigen-specific and negative control antigens for the immune adherence hemagglutination assay were prepared from cell extracts of the Epstein-Barr virus producer P3HR-1 and the Epstein-Barr virus genome-negative BJAB lymphoblastoid cell lines, respectively. As the immune adherence hemagglutination assay can be used to titrate antibodies to both the heterophil antigen of the Paul-Bunnell type and to virus capsid antigen, it offers a promising alternative to the immunofluorescence methods in the serodiagnosis of Epstein-Barr virus infections which can be performed by most diagnostic laboratories.
E T Lennette, and
E Ward, and
G Henle, and
W Henle
September 1992,
Casopis lekaru ceskych,
E T Lennette, and
E Ward, and
G Henle, and
W Henle
February 1982,
Journal of clinical microbiology,
E T Lennette, and
E Ward, and
G Henle, and
W Henle
February 1977,
International journal of cancer,
E T Lennette, and
E Ward, and
G Henle, and
W Henle
January 1976,
Neoplasma,
E T Lennette, and
E Ward, and
G Henle, and
W Henle
February 1978,
Lancet (London, England),
E T Lennette, and
E Ward, and
G Henle, and
W Henle
October 1977,
American journal of epidemiology,
E T Lennette, and
E Ward, and
G Henle, and
W Henle
March 1977,
Journal of the National Cancer Institute,
E T Lennette, and
E Ward, and
G Henle, and
W Henle
February 1998,
Disease markers,
E T Lennette, and
E Ward, and
G Henle, and
W Henle
January 1997,
Journal of virological methods,
E T Lennette, and
E Ward, and
G Henle, and
W Henle
January 1978,
Journal of clinical microbiology,
